Abstract
Naïve antibody libraries provide a rich resource for the identification of binding domains against targets of therapeutic interest. Being naïve in nature means a lack in antigen bias, resulting in a breadth of diversity with respect to epitopes that can be successfully targeted. In combination with display-based technology platforms, selection strategies allow for the generation of ortholog cross-reactive binding domains which enable critical preclinical proof-of-concept studies. However, naïve binding domains often suffer from low target affinity. In addition, construction of large naïve libraries results in non-native pairing of heavy and light v-domains which can present a challenge to molecular stability. Here we describe effective methods for the parallel evolution of antibody affinity and thermal stability which couple mutant antibody library phage display with carefully designed selection strategies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bargou R, Leo E, Zugmaier G, Klinger M et al (2008) Tumor regression in cancer patients by very low doses of a T cell-engaging antibody. Science 321:974–977
Topp MS, Gokbuget N, Zugmaier G, Degenhard E et al (2012) Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL. Blood 120:5185–5187
Mabry R, Gilbertson DG, Frank A, Vu T et al (2010) A dual-targeting PDGFRbeta/VEGF-A molecule assembled from stable antibody fragments demonstrates anti-angiogenic activity in vitro and in vivo. MAbs 2:20–34
Mabry R, Lewis KE, Moore M, McKernan PA, Bukowski TR, Bontadelli K, Brender T, Okada S, Lum K, West J et al (2010) Engineering of stable bispecific antibodies targeting IL-17A and IL-23. Protein Eng Des Sel 23:115–127
Orcutt KD, Ackerman ME, Cieslewicz M et al (2009) A modular IgG-scFv bispecific antibody topology. Protein Eng Des Sel 23(4):221–228
Michaelson JS, Demarest SJ et al (2009) Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTbetaR. MAbs 1:128–141
Miller BR, Demarest SJ, Lugovskoy A, Huang F, Wu X, Snyder WB, Croner LJ, Wang N, Amatucci A, Michaelson JS et al (2010) Stability engineering of scFvs for the development of bispecific and multivalent antibodies. Protein Eng Des Sel 23:549–557
Jordan JL, Arndt JW et al (2009) Structural understanding of stabilization patterns in engineered bispecific Ig-like antibody molecules. Proteins 77:832–841
Andris-Widhopf J, Rader C, Steinberger P, fuller R, Barbas CF III (2000) Methods for the generation of chicken monoclonal antibody fragments by phage display. J Immunol Methods 242:159–181
Finlay WJ, Bloom L, Varghese S, Autin B, Cunningham O (2017) Optimized generation of high-affinity, high-specificity single-chain Fv antibodies from multi-antigen immunized chickens. Methods Mol Biol 1485:319–338
Bostrom J, Lee CV, Haber L, Fuh G (2009) Improving antibody binding affinity and specificity for therapeutic development. In: Dimitrov A (ed) Therapeutic antibodies. Methods in molecular biology (methods and protocols), vol 525. Humana Press, New York
Fennell BJ, McDonnell B, Tam AS, Cunningham O et al (2013) CDR-restricted engineering of native human scFvs creates highly stable and soluble bifunctional antibodies for subcutaneous delivery. MAbs 5(6):882–895
Jespers L, Schon O, Famm K, Winter G (2004) Aggregation-resistant domain antibodies selected on phage by heat denaturation. Nat Biotechnol 22:1161–1165
Finlay WJ, Cunningham O et al (2009) Affinity maturation of a humanized rat antibody for anti-rage therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regions. J Mol Biol 388(3):541–558
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Franklin, E., Cunningham, O., Fennell, B. (2018). Parallel Evolution of Antibody Affinity and Thermal Stability for Optimal Biotherapeutic Development. In: Nevoltris, D., Chames, P. (eds) Antibody Engineering. Methods in Molecular Biology, vol 1827. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8648-4_23
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8648-4_23
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8647-7
Online ISBN: 978-1-4939-8648-4
eBook Packages: Springer Protocols